1. Home
  2. ANVS vs ALTS Comparison

ANVS vs ALTS Comparison

Compare ANVS & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • ALTS
  • Stock Information
  • Founded
  • ANVS 2008
  • ALTS 1976
  • Country
  • ANVS United States
  • ALTS United States
  • Employees
  • ANVS N/A
  • ALTS N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • ALTS
  • Sector
  • ANVS Health Care
  • ALTS
  • Exchange
  • ANVS Nasdaq
  • ALTS NYSE
  • Market Cap
  • ANVS 44.6M
  • ALTS 159.4M
  • IPO Year
  • ANVS 2020
  • ALTS N/A
  • Fundamental
  • Price
  • ANVS $2.36
  • ALTS $7.85
  • Analyst Decision
  • ANVS Strong Buy
  • ALTS
  • Analyst Count
  • ANVS 4
  • ALTS 0
  • Target Price
  • ANVS $18.00
  • ALTS N/A
  • AVG Volume (30 Days)
  • ANVS 485.7K
  • ALTS 298.8K
  • Earning Date
  • ANVS 08-14-2025
  • ALTS 08-18-2025
  • Dividend Yield
  • ANVS N/A
  • ALTS N/A
  • EPS Growth
  • ANVS N/A
  • ALTS N/A
  • EPS
  • ANVS N/A
  • ALTS N/A
  • Revenue
  • ANVS N/A
  • ALTS $18,046,000.00
  • Revenue This Year
  • ANVS N/A
  • ALTS $185.91
  • Revenue Next Year
  • ANVS N/A
  • ALTS $64.93
  • P/E Ratio
  • ANVS N/A
  • ALTS N/A
  • Revenue Growth
  • ANVS N/A
  • ALTS N/A
  • 52 Week Low
  • ANVS $1.11
  • ALTS $1.29
  • 52 Week High
  • ANVS $17.88
  • ALTS $10.95
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 48.29
  • ALTS 47.87
  • Support Level
  • ANVS $2.05
  • ALTS $6.62
  • Resistance Level
  • ANVS $3.18
  • ALTS $10.38
  • Average True Range (ATR)
  • ANVS 0.26
  • ALTS 1.04
  • MACD
  • ANVS -0.08
  • ALTS -0.29
  • Stochastic Oscillator
  • ANVS 27.43
  • ALTS 38.52

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About ALTS ALT5 SIGMA CORPORATION

ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.

Share on Social Networks: